Mycophenolate Sodium(Ref.Brand:Myfortic®(EU&US) Generics

Form: Tablet

Strength: 180mg , 360 mg

Reference Brands:

Category: Nephrology

Mycophenolate Sodium Tablets are widely used in nephrology to prevent organ rejection in kidney transplant patients. This immunosuppressive agent, known for its delayed-release formulation, reduces gastrointestinal side effects while maintaining therapeutic efficacy. It is commonly marketed under the brand name Myfortic® in both the US and EU. Mycophenolate Sodium works by inhibiting the proliferation of T and B lymphocytes, crucial for immune response control post-transplantation. Ideal for inclusion in Pharma B2B nephrology product portfolios, these tablets offer high-quality, GMP-compliant manufacturing for global partners. Source Mycophenolate Sodium Tablets today to meet demand in renal care and transplant immunosuppression therapies. Mycophenolate Sodium Tablets are widely used in nephrology to prevent organ rejection in kidney transplant patients. This immunosuppressive agent, known for its delayed-release formulation, reduces gastrointestinal side effects while maintaining therapeutic efficacy. It is commonly marketed under the brand name Myfortic® in both the US and EU. Mycophenolate Sodium works by inhibiting the proliferation of T and B lymphocytes, crucial for immune response control post-transplantation. Ideal for inclusion in Pharma B2B nephrology product portfolios, these tablets offer high-quality, GMP-compliant manufacturing for global partners. Source Mycophenolate Sodium Tablets today to meet demand in renal care and transplant immunosuppression therapies.